Try our beta test site
109 studies found for:    Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Show Display Options
Rank Status Study
21 Not yet recruiting Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy
Condition: Pain, Postoperative
Interventions: Drug: Morphine;   Drug: Oxycodone
22 Recruiting Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Conditions: Adverse Drug Event;   Adverse Drug Reaction;   Chinese Medicine;   Anaphylactic Reaction
Intervention: Drug: Breviscapine Powder-Injection
23 Recruiting Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
Conditions: Drug-Related Side Effects and Adverse Reactions;   Epidermal Growth Factor
Interventions: Drug: Repair Control EGF®;   Drug: Cream without rhEGF
24 Recruiting Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
Conditions: Drug-Related Side Effects and Adverse Reactions;   Epidermal Growth Factor
Interventions: Drug: Repair Control EGF®;   Drug: Cream without rhEGF
25 Recruiting Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Conditions: Safety Surveillance;   Adverse Drug Events;   Adverse Drug Reactions;   Severe Adverse Events;   Severe Adverse Reactions
Intervention: Drug: Compound Kuh-seng Injection
26 Recruiting Reduction of Adverse Drug Events and Readmissions
Condition: Pharmacogenomic Testing for Medication Management
Intervention:
27 Recruiting Post-operative Pain Control After Pediatric Adenotonsillectomy
Conditions: Recurrent Tonsillitis;   Obstructive Sleep Apnea;   Sleep Disordered Breathing;   Adverse Reaction to Drug
Interventions: Drug: Ibuprofen;   Drug: Hydrocodone-Acetaminophen
28 Recruiting A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib and Erlotinib, in Non-small Cell Lung Cancer(NSCLC)Treatment
Conditions: Non-small Cell Lung Cancer (NSCLC);;   EGFR-TKI Resistant Mutation;;   EGFR-TKI Sensitizing Mutation;;   Germline Mutations
Intervention:
29 Recruiting Use of Public Health Surveillance Models in the French National Health System Database
Conditions: Atrial Fibrillation;   Anticoagulants;   Pharmacoepidemiology
Intervention: Drug: Dabigatran
30 Recruiting PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Conditions: Metastatic Breast Cancer;   Toxicity;   Neurotoxicity;   Drug Toxicity;   Adverse Drug Event
Intervention: Drug: ERIBULIN MESYLATE
31 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
32 Recruiting Acupuncture Prevents Chemobrain in Breast Cancer Patients
Conditions: Chemo-brain;   Drug-Related Side Effects and Adverse Reactions;   Mild Cognitive Impairment;   Breast Cancer
Interventions: Procedure: Dense cranial electroacupuncture stimulation;   Procedure: Body acupuncture;   Procedure: Least acupuncture stimulation;   Drug: Cytoxan-containing chemotherapy regimens
33 Recruiting Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
Conditions: Central Line-Associated Bloodstream Infection (CLABSI);   Venous Thromboembolism;   Patient Fall;   Catheter-Associated Infection;   Severe Hypoglycemia;   Opioid-Related Severe Adverse Drug Event;   Hospital Acquired Pressure Ulcer;   Adverse Drug Event;   Severe Hospital Acquired Delerium;   Rapid Response Related to Arrhythmia
Intervention: Behavioral: Patient Safety health information technology
34 Recruiting Divided Drug Delivery
Condition: Hospitalized for Voluntary Drug Intoxication
Interventions: Other: Weekly divided delivery;   Other: Monthly divided delivery
35 Recruiting Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials
Conditions: Toxicity, Drug;   Maculopathy
Intervention: Device: spectral domain optical coherence tomography C-scan and multifocal electroretinogram
36 Recruiting High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs
Conditions: Self Efficacy;   Drug Toxicity
Intervention: Drug: Erlotinib or Gefitinib
37 Recruiting Genetics of QT Prolongation With Antiarrhythmics
Conditions: Long QT Syndrome;   Drug Toxicity
Intervention: Drug: Dofetilide and/or sotalol
38 Recruiting Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients
Condition: Adrenal Insufficiency
Intervention: Other: ACTH stimulation test
39 Recruiting Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
Conditions: Renal Insufficiency,Chronic;   Hiv;   Therapeutic Agent Toxicity
Interventions: Drug: tenofovir alafenamide;   Drug: abacavir
40 Recruiting Allergy Testing of Patients Labeled as Penicillin Allergic
Condition: Drug Hypersensitivity
Intervention: Other: Penicillin allergy testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.